- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (01/05/2021)
- Gwreiddiol (a wnaed Fel)
Point in time view as at 01/05/2021.
There are currently no known outstanding effects for the The Medical Devices (Amendment etc.) (EU Exit) Regulations 2019, Section 9.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
9.—(1) Part VII of the 2002 Regulations is amended as follows.
(2) In regulation 59 M1(interpretation of Part VII)—
(a)omit the definition of “registrable device”;
(b)in the definition of “relevant device” after “IV” insert “ or a device for the purposes of Part VIII or IX. ”.
(3) M2In regulation 60 (designation etc. of authorised representatives)—
(a)for the heading substitute “ Status of UK responsible person ”;
(b)omit paragraphs (1) and (2);
(c)for paragraph (3), substitute—
“(3) A UK responsible person—
(a)may be proceeded against as a person placing the device on the market for the purposes of these regulations;
(b)in relation to the supply of the device to a person within the United Kingdom after it has been placed on the market, may be proceeded against as a person supplying the device after it has been placed on the market.”.
[F1(d)in paragraph (4)—
(i)for “an authorised representative of a manufacturer of a device” substitute “ a UK responsible person ”;
(ii)for “the single authorised representative of the manufacturer” substitute “ a UK responsible person ”.]
[F2(4) In regulation 61 (enforcement etc.)—
(a)for “CE marking” in both places substitute “UK marking”;
(b)in paragraph (8)(a)(i), after “essential requirement” insert “, a general safety and performance requirement”;
(c)in paragraph (8)(a)(ii), omit “set out in the Medical Devices Directives”;
(d)in paragraph (8)(a)(ii)(aa), for “his authorised representative” substitute “their UK responsible person”.]
(5) In regulation 62 (compliance notices) in paragraph (1)—
(i)after “performance evaluation” insert “ or study ”;
(ii)for “the manufacturer or his authorised representative” substitute “ any person ”;
[F3(iii)in sub-paragraph (c) omit “and, where applicable any relevant provision of the Medical Devices Directives”.]
(6) In regulation 63 M3 (restriction notices) in paragraph (1)—
(i)in sub-paragraph (a), after “performance evaluation” insert “ or study ”;
(ii)in sub-paragraph (b), after “performance evaluation” insert “ or study ”.
[F4(6A) In regulation 64 (notification of decisions etc)—
(a)in paragraph (1)(c), for “him or his authorised representative” substitute “the applicant or the applicant’s UK responsible person”;
(b)in paragraph (2)—
(i)for “a UK notified body” substitute “an approved body”;
(ii)for “his authorised representative” substitute “their UK responsible person”.]
(7) Omit regulation 65(centralised system of records etc.).
(8) In regulation 67 M4 (review), for “2019” substitute “ 2025 ”.
(9) Omit Schedule 1 M5 (association agreements).
(10) For Schedule 2 M6 (mutual recognition agreements) substitute—
Regulation 1A
— Australia
— New Zealand
— Canada
— The United States of America
— The Swiss Confederation”.
Textual Amendments
F1Reg. 9(3)(d) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/1385), reg. 1, Sch. 2 para. 8; 2020 c. 1, Sch. 5 para. 1(1)
F2Reg. 9(4) substituted (31.12.2020 immediately before IP completion day) by The Medical Devices (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1478), reg. 1(3), Sch. 2 para. 51
F3Reg. 9(5)(iii) inserted (31.12.2020 immediately before IP completion day) by The Medical Devices (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1478), reg. 1(3), Sch. 2 para. 52
F4Reg. 9(6A) inserted (31.12.2020 immediately before IP completion day) by The Medical Devices (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1478), reg. 1(3), Sch. 2 para. 53
Commencement Information
I1Reg. 9(1)(3)-(10) in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)
I2Reg. 9(2) in force at 1.5.2021, see reg. 1(2)(e) (as amended by S.I. 2020/1478, reg. 1(3), Sch. 2 para. 2(c))
Marginal Citations
M1Regulation 59 was amended by S.I. 2003/1697.
M2Regulation 60 was amended by S.I. 2008/2936.
M3Regulation 63 was amended by S.I. 2008/2936.
M4Regulation 67 was inserted by S.I. 2013/2327.
M5Schedule 1 was amended by 2013/2327.
M6Schedule 2 was amended by S.I. 2013/2327.
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys